<p>List of phosphopeptides that show significant changes in abundance in response to CSPG treatment with mean log<sub>2</sub> (CSPG/Control) >0.5 or<−0.5.</p
<p>Results of TP421 proteomics screen for proteins whose total abundances were decreased in response...
<p>List of the 61 differentially expressed proteins identified in pooled fractions F1, using a 0.95 ...
2.1: List of phopshopeptides identified in the phosphoproteomic analysis of 1G5DC control parasite. ...
<p>List of the proteins that showed significantly (p <0.05) altered abundance in LPS and LPS+INU sam...
<p>Phosphopeptides shown are a selection where a confident assessment of a common decrease or increa...
The data are expressed in fold-changes in the phosphopeptides amounts in the phosphocofilin spot (co...
<p>(<b>A</b>) Strategy used for iTRAQ-based quantitative phosphoproteomics of CSPG-treated mouse CGN...
<p>Volcano plots showing −log<sub>10</sub> P-values in relation to log<sub>2</sub> T/NT ratios for; ...
<p>Here are examples of phosphopeptides that contain activator and inhibitor phosphorylation sites o...
<p>N/a, not applicable, indicates that the phosphopeptides were not detected in this group and were ...
<p>Changes in phosphorylation abundance are represented as heatmaps from 5 replicate experiments as ...
<p>(A) Overview of FunCat categories of proteins harboring the identified phosphopeptides. The upper...
<p>Results of TP421 proteomics screen for proteins whose total abundances were increased in response...
<p>Results of TP421 proteomics screen for proteins whose phosphorylation levels were changed in resp...
<p>(<b>A</b>) Volcano plot visualising quantified phospho-sites with significant differences between...
<p>Results of TP421 proteomics screen for proteins whose total abundances were decreased in response...
<p>List of the 61 differentially expressed proteins identified in pooled fractions F1, using a 0.95 ...
2.1: List of phopshopeptides identified in the phosphoproteomic analysis of 1G5DC control parasite. ...
<p>List of the proteins that showed significantly (p <0.05) altered abundance in LPS and LPS+INU sam...
<p>Phosphopeptides shown are a selection where a confident assessment of a common decrease or increa...
The data are expressed in fold-changes in the phosphopeptides amounts in the phosphocofilin spot (co...
<p>(<b>A</b>) Strategy used for iTRAQ-based quantitative phosphoproteomics of CSPG-treated mouse CGN...
<p>Volcano plots showing −log<sub>10</sub> P-values in relation to log<sub>2</sub> T/NT ratios for; ...
<p>Here are examples of phosphopeptides that contain activator and inhibitor phosphorylation sites o...
<p>N/a, not applicable, indicates that the phosphopeptides were not detected in this group and were ...
<p>Changes in phosphorylation abundance are represented as heatmaps from 5 replicate experiments as ...
<p>(A) Overview of FunCat categories of proteins harboring the identified phosphopeptides. The upper...
<p>Results of TP421 proteomics screen for proteins whose total abundances were increased in response...
<p>Results of TP421 proteomics screen for proteins whose phosphorylation levels were changed in resp...
<p>(<b>A</b>) Volcano plot visualising quantified phospho-sites with significant differences between...
<p>Results of TP421 proteomics screen for proteins whose total abundances were decreased in response...
<p>List of the 61 differentially expressed proteins identified in pooled fractions F1, using a 0.95 ...
2.1: List of phopshopeptides identified in the phosphoproteomic analysis of 1G5DC control parasite. ...